UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AngioJet Pharmacomechanical Thrombectomy and Catheter Directed Thrombolysis vs. Catheter Directed Thrombolysis Alone for the Treatment of Iliofemoral Deep Vein Thrombosis: A Single Centre Retrospective Cohort Study

European journal of vascular and endovascular surgery, 2020-10, Vol.60 (4), p.578-585

2020

Volltextzugriff (PDF)

Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent

European journal of vascular and endovascular surgery, 2018-11, Vol.56 (5), p.710-718

2018

Volltextzugriff (PDF)

Idraparinux versus Standard Therapy for Venous Thromboembolic Disease

The New England journal of medicine, 2007-09, Vol.357 (11), p.1094-1104

2007

Volltextzugriff (PDF)

Machine learning to predict venous thrombosis in acutely ill medical patients

Research and practice in thrombosis and haemostasis, 2020-02, Vol.4 (2), p.230-237

2020

Volltextzugriff (PDF)

Interview with Alexander Cohen

Future cardiology, 2017-05, Vol.13 (3), p.207-209

Cohen, Alexander (Ander)

2017

Volltextzugriff (PDF)

Extended Prophylaxis of Venous Thromboembolism with Idraparinux

The New England journal of medicine, 2007-09, Vol.357 (11), p.1105-1112

2007

Volltextzugriff (PDF)

A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)

Health technology assessment (Winchester, England), 2015-10, Vol.19 (83), p.vii-94

2015

Volltextzugriff (PDF)

Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis, 2016-04, Vol.22 (3), p.209-221

2016

Volltextzugriff (PDF)

NOACs for thromboprophylaxis in medical patients

Best practice & research. Clinical haematology, 2013-06, Vol.26 (2), p.183-190

2013

Volltextzugriff (PDF)

Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

Thrombosis and haemostasis, 2021-05, Vol.121 (5), p.616-624

2021

Volltextzugriff (PDF)

New agents for DOAC reversal: a practical management review

The British journal of cardiology, 2022-01, Vol.29 (1)

2022

Volltextzugriff (PDF)

d-Dimer elevation and adverse outcomes

Journal of thrombosis and thrombolysis, 2015-01, Vol.39 (1), p.55-59

2015

Volltextzugriff (PDF)

Simplifying venous thromboembolism management: a new and safer era

SA Orthopaedic Journal, 2012, Vol.11 (4), p.81-81

Cohen, Ander

2012

Volltextzugriff (PDF)

Early Outcomes Following Endoluminal Deep Venous Reconstruction Using Dedicated Venous Stents

Blood, 2015-12, Vol.126 (23), p.4721-4721

2015

Volltextzugriff (PDF)

COMPARISON OF ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY FOR THE EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A2086-A2086

2015

Volltextzugriff (PDF)

HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Journal of the American College of Cardiology, 2016, Vol.67 (13), p.2256-2256

2016

Volltextzugriff (PDF)

Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2021-07, Vol.9 (4), p.888-894

2021

Volltextzugriff (PDF)

The Efficacy and Safety of Pharmacological Prophylaxis of VTE Following Elective Knee or Hip Replacement: Systematic Review and Network Meta-Analysis

Blood, 2011-11, Vol.118 (21), p.2314-2314

2011

Volltextzugriff (PDF)

COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT ACTIVE CANCER

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.1926-1926

2019

Volltextzugriff (PDF)

Patency Rates After Stenting Across the Inguinal Ligament for Treatment of Post-Thrombotic Syndrome Using Nitinol Venous Stents

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2017-01, Vol.5 (1), p.148-148

2017

Volltextzugriff (PDF)

PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.1944-1944

2019

Volltextzugriff (PDF)

HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.2256-2256

2016

Volltextzugriff (PDF)

RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.2061-2061

2016

Volltextzugriff (PDF)

Abstract 16280: Betrixaban Reduced the Occurrence of Major Adverse Cardiovascular Events Among Acute Medically Ill Patients With a History of Myocardial Infarction or Stroke: Insights From the APEX Trial

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A16280-A16280

2018

Volltextzugriff (PDF)

Simplifying venous thromboembolism management: a new and safer era

Cardiovascular journal of South Africa, 2012-11, Vol.23 (10), p.574

Hardy, G

2012

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(139)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AngioJet Pharmacomechanical Thrombectomy and Catheter Directed Thrombolysis vs. Catheter Directed Thrombolysis Alone for the Treatment of Iliofemoral Deep Vein Thrombosis: A Single Centre Retrospective Cohort Study

Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent

Idraparinux versus Standard Therapy for Venous Thromboembolic Disease

Machine learning to predict venous thrombosis in acutely ill medical patients

Interview with Alexander Cohen

Extended Prophylaxis of Venous Thromboembolism with Idraparinux

A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)

Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism

NOACs for thromboprophylaxis in medical patients

Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

New agents for DOAC reversal: a practical management review

d-Dimer elevation and adverse outcomes

Simplifying venous thromboembolism management: a new and safer era

Early Outcomes Following Endoluminal Deep Venous Reconstruction Using Dedicated Venous Stents

COMPARISON OF ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY FOR THE EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents

The Efficacy and Safety of Pharmacological Prophylaxis of VTE Following Elective Knee or Hip Replacement: Systematic Review and Network Meta-Analysis

COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT ACTIVE CANCER

Patency Rates After Stenting Across the Inguinal Ligament for Treatment of Post-Thrombotic Syndrome Using Nitinol Venous Stents

PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL

HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY

Abstract 16280: Betrixaban Reduced the Occurrence of Major Adverse Cardiovascular Events Among Acute Medically Ill Patients With a History of Myocardial Infarction or Stroke: Insights From the APEX Trial

Simplifying venous thromboembolism management: a new and safer era

Suchergebnisse filtern